Introducing safer injecting facilities (SIFs) in the Republic of Ireland: ‘Chipping away’ at policy change

References

• Broadhead RS, Borch CA, Hulst YV, Farrell J, Villemez WJ, Altice RL. Safer injection sites in New York City: A utilization survey of injection drug users. Journal of Drug Issues 2003; 33(3)733–750
   Web of Science ®Google Scholar
• Broadhead RS, Kerr TH, Grund JP, Altice RL. Safer injecting facilities in North America: Their place in public policy and health initiatives. Journal of Drug Issues 2002; 32: 329–356
   Web of Science ®Google Scholar
• Butler S. Alcohol, drugs and health promotion. Institute of Public Administration, DublinIreland 2002a
   Google Scholar
• Butler S. The making of the Methadone Protocol: The Irish system?. Drugs: Education, Prevention and Policy 2002b; 9(4)311–324
   Web of Science ®Google Scholar
• Byrne R. Opiate-related deaths investigated by the Dublin and county coroners, l998–2001 Addiction Research Centre, Briefing Paper 2. Trinity College, DublinIreland 2002
   Google Scholar
• Corr C. Engaging the hard to reach: An evaluation of an outreach service. Pieces of the Jigsaw. Merchants Quay Project, DublinIreland 2003
   Google Scholar
• Cox G, Lawless M. Wherever I lay my hat. Merchants Quay Project, DublinIreland 1999
   Google Scholar
• Dean G, Bradshaw J, Lavelle P. Drug misuse in Dublin l982–1983: Investigation in a north central Dublin area. Medio-Social Research Board, DublinIreland 1983
   Google Scholar
• De Jong W, Weber U. The professional acceptance of drug use: A closer look at drug consumption rooms in the Netherlands, Germany and Switzerland. International Journal of Drug Policy 1999; 10: 99–108
   Google Scholar
• Dolan K, Kimber J, Fray C, Fitzgerald J, McDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug and Alcohol Review 2000; 19: 337–346
   Web of Science ®Google Scholar
• EMCDDA. European report on drug consumption rooms. European Monitoring Centre for Drugs and Drug Addiction, Luxembourg 2004
   Google Scholar
• Fry CL. Injecting drug user attitudes towards rules for supervised injecting rooms: Implications for uptake. International Journal of Drug Policy 2002; 13: 471–476
   Google Scholar
• Green T, Hankins C, Palmer D, Boivin JF, Platt R. Ascertaining the need for a supervised injecting facility (SIF): The burden of public injecting in Montreal, Canada. Journal of Drug Issues 2003; 33: 713–731
   Web of Science ®Google Scholar
• Inciardi JA, Harrison LD. Harm reduction: National and international perspectives. Sage, London 2000, (Eds.)
   Google Scholar
• Jepsen J. The Danish harm reduction debate: Actors and influences. Illicit drugs: Patterns of use—patterns of response. Proceedings of the l0th Annual Conference on Drug Use and Drug Policy in Europe. 2000, UHL Springer. Studien Verlag, Vienna, 91–101
   Google Scholar
• Kimber K, Dolan K, Beek V, Hedrich D, Zurhold H. Drug consumption facilities: An update since 2000. Drug and Alcohol Review 2003; 22: 227–233
   PubMed Web of Science ®Google Scholar
• Long J, Lynn E, Keating J. Drug related deaths in Ireland, 1990–2002. Health Research Board, Dublin 2005
   Google Scholar
• Mason J. Qualitative researching. Blackwell, Oxford, UK 1993
   Google Scholar
• Malkin I, Elliott R, McRae R. Supervised injection facilities and international law. Journal of Drug Issues 2003; 33(3)539–578
   Web of Science ®Google Scholar
• MSIC Evaluation Committee. Final report on the evaluation of the Sydney Medically Supervised Injecting Centre. MSIC, SydneyAustralia 2003
   Google Scholar
• Report of the Steering Group. Mid-term Review of the National Drugs Strategy 2001–2008. 2005. Department of Community, Rural and Gaeltacht Affairs, DublinIreland
   Google Scholar
• Moore G, McCarthy P, MacNeela P, MacGabhann L, Philbin M, Proudfoot D. A review of harm reduction approaches in Ireland and evidence from the international literature. Stationery Office, DublinIreland 2004
   Google Scholar
• National Drugs Strategy 2001–2008. Building on experience. Stationery Office, DublinIreland 2001
   Google Scholar
• Nutbeam D, Blakey V, Pates R. The prevention of HIV infection from injecting drug use: A review of health promotion approaches. Social Science and Medicine 1991; 33: 997–983
   Google Scholar
• Riley D. Injecting drug use and HIV/AIDS: Policy issues. Injecting drug use and HIV/AIDS: Legal and ethical issues—background papers . Canadian HIV/AIDS Legal Network, MontrealCanada 1999; 9
   Google Scholar
• Roberts M, Klein A, Trace M. The Beckley Foundation Drug Policy Programme. DrugScope Briefing Paper No. 3. Drug consumption rooms. 2004, 1–8
   Google Scholar
• Wolf J, Linseen L, de Graaf I. Drug consumption facilities in the Netherlands. Journal of Drug Issues 2003; 33(3)640–662
   Google Scholar
• Zurhold H, Degkwitz P, Verthein U, Haasen C. Drug consumption rooms in Hamburg, Germany: Evaluation of the effects on harm reduction and the reduction of public nuisance. Journal of Drug Issues 2003; 33(3)663–688
   Web of Science ®Google Scholar